Abstract
Seventy patients with Hodgkin's disease have been treated with a combination of chlorambucil, vinblastine, procarbazine and prednisolone (Ch1VPP). The complete remission rate of 75-7% compares well with that produced by other combinations. The combination is non-toxic, easily administered and can be given safely to outpatients. Its main advantage is that it is far less upsetting to patients than combinations containing nitrogen mustard. © 1977, The British Empire Cancer Campaign for Research. All rights reserved.
Cite
CITATION STYLE
McElwain, T. J., Toy, J., Smith, E., Peckham, M. J., & Austin, D. E. (1977). A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of hodgkin’s disease. British Journal of Cancer, 36(2), 276–280. https://doi.org/10.1038/bjc.1977.187
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
